The management pathway for lesions of uncertain malignant potential (B3) has changed to include the use of vacuum assisted biopsy equipment in a minimally invasive procedure with a view of minimising diagnostic open surgical biopsy rates. The Mammotome name is synonymous with vacuum assisted biopsy worldwide. We have partnered with Mammotome in the UK to help clinical teams implement VAE services and minimise the number of diagnostic open surgical biopsies. Mammotome revolve can accurately capture large, contiguous samples of breast tissue to satisfy B3 guidelines or to therapeutically excise known benign lesions such as fibroadenomas.
Enough about us, let’s talk about you.
We want to make sure you get the best out of the devices we supply. Please contact our Customer Experience Team and they will point you in the direction of the best person to help you.